Omalizumab, an anti-IgE antibody, improves both asthma- and rhinitis-related quality of life in patients with concomitant moderate-severe disease*1

✍ Scribed by HARNEST, U

• Book ID: 119273917
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 26 KB
• Volume: 113
• Category: Article
• ISSN: 1097-6825
• DOI: 10.1016/j.jaci.2004.01.067